Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 28;19(3):134.
doi: 10.3390/md19030134.

Metabolites from Marine Sponges and Their Potential to Treat Malarial Protozoan Parasites Infection: A Systematic Review

Affiliations

Metabolites from Marine Sponges and Their Potential to Treat Malarial Protozoan Parasites Infection: A Systematic Review

Anna Caroline Campos Aguiar et al. Mar Drugs. .

Abstract

Malaria is an infectious disease caused by protozoan parasites of the Plasmodium genus through the bite of female Anopheles mosquitoes, affecting 228 million people and causing 415 thousand deaths in 2018. Artemisinin-based combination therapies (ACTs) are the most recommended treatment for malaria; however, the emergence of multidrug resistance has unfortunately limited their effects and challenged the field. In this context, the ocean and its rich biodiversity have emerged as a very promising resource of bioactive compounds and secondary metabolites from different marine organisms. This systematic review of the literature focuses on the advances achieved in the search for new antimalarials from marine sponges, which are ancient organisms that developed defense mechanisms in a hostile environment. The principal inclusion criterion for analysis was articles with compounds with IC50 below 10 µM or 10 µg/mL against P. falciparum culture. The secondary metabolites identified include alkaloids, terpenoids, polyketides endoperoxides and glycosphingolipids. The structural features of active compounds selected in this review may be an interesting scaffold to inspire synthetic development of new antimalarials for selectively targeting parasite cell metabolism.

Keywords: Plasmodium; antimalarial; malaria; resistance; sponge.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flow diagram of literature search and selection criteria used in the present review adapted from PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis).
Figure 2
Figure 2
Number of published papers reporting the antimalarial activity of new compounds from marine sources or plants in the past 10 years.
Figure 3
Figure 3
Chemical class of compounds (259) identified in the reviewed articles (37).
Figure 4
Figure 4
Alkaloids from marine sponges with antimalarial effect revealed moderate inhibitory activity on P. falciparum protein kinases (PfPK5 and Pfnek-1) and P. falciparum enoyl-ACP reductase (PfFabI).
Figure 5
Figure 5
Meroterpenes from a marine sponge with antimalarial effect revealed inhibitory activity on P. falciparum protein kinase (Pfnek-1) and P. falciparum farnesyl transferase.
Figure 6
Figure 6
Histogram of related mechanisms of action for each chemical compound class in different cell models indicated by the literature.

Similar articles

Cited by

References

    1. Crompton P.D., Moebius J., Portugal S., Waisberg M., Hart G., Garver L.S., Miller L.H., Barillas C., Pierce S.K. Malaria immunity in man and mosquito: Insights into unsolved mysteries of a deadly infectious disease. Annu. Rev. Immunol. 2014;32:157–187. doi: 10.1146/annurev-immunol-032713-120220. - DOI - PMC - PubMed
    1. World Health Organization . WHO Malaria Report 2017. World Health Organization; Geneva, Switzerland: 2017.
    1. Wicht K.J., Mok S., Fidock D.A. Molecular Mechanisms of Drug Resistance in Plasmodium falciparum Malaria. Annu. Rev. Microbiol. 2020;74:431–454. doi: 10.1146/annurev-micro-020518-115546. - DOI - PMC - PubMed
    1. Roussel C., Caumes E., Thellier M., Ndour P.A., Buffet P.A., Jauréguiberry S. Artesunate to treat severe malaria in travellers: Review of efficacy and safety and practical implications. J. Travel Med. 2017;24:taw093. doi: 10.1093/jtm/taw093. - DOI - PubMed
    1. Bridgford J.L., Xie S.C., Cobbold S.A., Pasaje C.F.A., Herrmann S., Yang T., Gillett D.L., Dick L.R., Ralph S.A., Dogovski C., et al. Artemisinin kills malaria parasites by damaging proteins and inhibiting the proteasome. Nat. Commun. 2018;9:1–9. doi: 10.1038/s41467-018-06221-1. - DOI - PMC - PubMed

Publication types